Literature DB >> 20971937

The effect of D-cycloserine on immediate vs. delayed extinction of learned fear.

Julia M Langton1, Rick Richardson.   

Abstract

We compared the effect of D-cycloserine (DCS) on immediate (10 min after conditioning) and delayed (24 h after conditioning) extinction of learned fear in rats. DCS facilitated both immediate and delayed extinction when the drug was administered after extinction training. However, DCS did not facilitate immediate extinction when administered prior to extinction training (i.e., when the interval between drug administration and shock was reduced). In addition, administering five, but not two, shocks prior to extinction training disrupted the facilitating effects of DCS on delayed extinction. These results suggest that aversive experiences prior to DCS administration can prevent it from facilitating extinction.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20971937     DOI: 10.1101/lm.1927310

Source DB:  PubMed          Journal:  Learn Mem        ISSN: 1072-0502            Impact factor:   2.460


  13 in total

Review 1.  Neural and cellular mechanisms of fear and extinction memory formation.

Authors:  Caitlin A Orsini; Stephen Maren
Journal:  Neurosci Biobehav Rev       Date:  2012-01-02       Impact factor: 8.989

Review 2.  Behavioral and neurobiological mechanisms of extinction in Pavlovian and instrumental learning.

Authors:  Travis P Todd; Drina Vurbic; Mark E Bouton
Journal:  Neurobiol Learn Mem       Date:  2013-08-30       Impact factor: 2.877

Review 3.  Mechanisms to medicines: elucidating neural and molecular substrates of fear extinction to identify novel treatments for anxiety disorders.

Authors:  Olena Bukalo; Courtney R Pinard; Andrew Holmes
Journal:  Br J Pharmacol       Date:  2014-07-23       Impact factor: 8.739

4.  Acute, but not chronic, exposure to d-cycloserine facilitates extinction and modulates spontaneous recovery of a conditioned taste aversion.

Authors:  G Andrew Mickley; Jennifer L Remus; Linnet Ramos; Gina N Wilson; Orion R Biesan; Kyle D Ketchesin
Journal:  Physiol Behav       Date:  2011-09-10

Review 5.  Pharmacological enhancement of fear reduction: preclinical models.

Authors:  Bronwyn M Graham; Julia M Langton; Rick Richardson
Journal:  Br J Pharmacol       Date:  2011-10       Impact factor: 8.739

Review 6.  Cognitive enhancers for anxiety disorders.

Authors:  Stefan G Hofmann; Jasper A J Smits; Anu Asnaani; Cassidy A Gutner; Michael W Otto
Journal:  Pharmacol Biochem Behav       Date:  2010-12-04       Impact factor: 3.533

Review 7.  Pharmacology of cognitive enhancers for exposure-based therapy of fear, anxiety and trauma-related disorders.

Authors:  N Singewald; C Schmuckermair; N Whittle; A Holmes; K J Ressler
Journal:  Pharmacol Ther       Date:  2014-12-27       Impact factor: 12.310

8.  Effects of pharmacological manipulations of NMDA-receptors on deliberation in the Multiple-T task.

Authors:  Anna Blumenthal; Adam Steiner; Kelsey Seeland; A David Redish
Journal:  Neurobiol Learn Mem       Date:  2011-02-04       Impact factor: 2.877

9.  A high-throughput clinical assay for testing drug facilitation of exposure therapy.

Authors:  Thomas L Rodebaugh; Cheri A Levinson; Eric J Lenze
Journal:  Depress Anxiety       Date:  2013-01-02       Impact factor: 6.505

10.  D-Cycloserine improves sociability in the BTBR T+ Itpr3tf/J mouse model of autism spectrum disorders with altered Ras/Raf/ERK1/2 signaling.

Authors:  Jessica A Burket; Andrew D Benson; Amy H Tang; Stephen I Deutsch
Journal:  Brain Res Bull       Date:  2013-05-15       Impact factor: 4.077

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.